Clinical Trials Directory

Trials / Completed

CompletedNCT02314546

Intranasal Midazolam in Children as a Pre-Operative Sedative

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Bassett Healthcare · Academic / Other
Sex
All
Age
18 Months – 7 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to see if adding a numbing medicine, xylocaine, to the nasal midazolam makes giving the midazolam easier and more comfortable without affecting how the midazolam works as a sedative.

Detailed description

Midazolam is often given before surgery to sedate a patient before anesthesia is given. Children are often given a small dose either by mouth or squirted into the nose. Children will often spit out the oral midazolam, making it difficult to know how much medicine, if any, they have received. Giving midazolam into the nose is more reliable, but children may complain of pain, stinging, and may become upset due to the discomfort. Nosebleeds may also occur when midazolam is squirted alone into the nose. The purpose of this study is to see if adding a numbing medicine, xylocaine, to the nasal midazolam makes giving the midazolam easier and more comfortable without affecting how the midazolam works as a sedative.

Conditions

Interventions

TypeNameDescription
DRUGMidazolamStudy participants will be randomly assigned to one of three treatment groups: * Group 1 - Placebo - Control patients will receive intranasal saline. * Group 2 - Nasal Midazolam Only - Patients will receive 0.2 mg/kg of intranasal midazolam. * Group 3 - Midazolam Plus Xylocaine - Patients will receive 0.2 mg/kg intranasal midazolam plus xylocaine 4% in a dose based on 25% of the volume of the midazolam.
DRUGxylocaineMidazolam Plus Xylocaine - Patients will receive 0.2 mg/kg intranasal midazolam plus xylocaine 4% in a dose based on 25% of the volume of the midazolam.
DRUGsaline placeboPlacebo - Control patients will receive intranasal saline.

Timeline

Start date
2011-12-01
Primary completion
2014-01-01
Completion
2014-01-01
First posted
2014-12-11
Last updated
2015-07-23
Results posted
2015-07-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02314546. Inclusion in this directory is not an endorsement.